Nanopore Protein Sequencing Landscape 2026 — PatSnap Eureka
Nanopore Protein Sequencing: Patent & Research Intelligence
Single-molecule protein identification via ionic current-blockade nanopores is transitioning from proof-of-concept to integrated chip-level devices. Explore the 2026 innovation landscape — biological pores, solid-state nanopores, signal algorithms, and IP white space — powered by PatSnap Eureka.
Extending Nanopore Sensing from DNA to Proteins
Nanopore protein sequencing occupies a distinct sub-domain within the broader nanopore sensing field. The foundational mechanism — threading a linearized analyte molecule through a nano-scale aperture embedded in a thin membrane while measuring characteristic ionic current blockade signatures — was originally developed for DNA and has now been redirected toward peptides and intact proteins.
Three key technical distinctions separate protein nanopore sequencing from its DNA counterpart: the absence of any protein amplification equivalent to PCR (making sensitivity an absolute requirement); the 20-amino acid alphabet versus a 4-nucleotide alphabet, requiring finer discrimination resolution; and the need to unfold native three-dimensional protein structures before translocation. These challenges define the current R&D frontier as tracked by PatSnap's IP analytics platform.
The technology promises to transform proteomics by enabling label-free, amplification-free protein identification with minimal sample volumes — with direct implications for precision medicine, single-cell proteomics, and biomarker discovery. Regulatory and standards context for such devices is actively developing at bodies including the WHO and national health agencies.
Key Technology Approaches in Nanopore Protein Sequencing
Patent and literature evidence across the 2026 landscape resolves into four distinct technical clusters, each targeting a different layer of the sequencing stack.
Engineered Biological Nanopore Channel Arrays
Designing series of protein nanopore channels whose geometries and inner-surface chemistries specifically recognize individual amino acids based on physicochemical properties — hydrophilicity, hydrophobicity, polarity, charge state. Each amino acid traverses sequentially through a customized pore, generating a characteristic ion-current signal. An array of micro-current detectors captures signals across many nanopores in parallel. Key example: the Nanjing University GB patent (2024) integrating amino acid screening chips, sequence-reading chips, and data processing systems into a unified platform.
MspA mutants · biological pore customizationSolid-State Nanopores for Single-Molecule Translocation
Synthetic apertures fabricated in silicon nitride, graphene, or MoS₂ offer geometrically tunable pore sizes and greater physical robustness than biological pores. For protein sequencing, sub-nanometer resolution is required to distinguish amino acids. Label-free optical readout methods — plasmonic enhancement, zero-mode waveguides — have emerged as a complementary or alternative signal modality to ionic current, as described by Istituto Italiano di Tecnologia (2022).
Si₃N₄ · graphene · MoS₂ · optical readoutAdaptive Bio-Inspired Nanopore Systems
Taking inspiration from natural protein behavior, adaptive nanopore designs combine biological recognition motifs with engineered pore architectures. The emphasis is on exploiting the inherent selectivity of biological nanopore structures to achieve sequence-level discrimination without requiring full translocation-based sequencing. CONCEPT Lab (2020) argues that biological nanopores functioning as single-molecule detectors can be repurposed for sequencing — contrasting with conventional Edman degradation, liquid chromatography, and mass spectrometry approaches.
Bio-inspired · label-free · single-molecule detectionSignal Processing & Algorithmic Discrimination
Even with a functional nanopore device, distinguishing 20 amino acids from ionic current time-series data requires sophisticated signal-processing methods. University of Notre Dame (2017) developed the "nanospectrum" algorithm — analyzing p-values for identification confidence against protein databases from blockade signals. The Nanjing University chip patent (2024) includes an integrated "data processing and constructing system" assembling standard nanopore channel model peptide sequence information into protein sequence outputs. Machine learning–based basecalling equivalents for proteins are expected to be foundational IP.
Nanospectrum algorithm · ML basecalling · real-time signalInnovation Signals Across the Nanopore Protein Sequencing Dataset
Patent and literature distribution across technology clusters and geographic origins, derived from the PatSnap Eureka dataset.
Technology Cluster Distribution
Records are evenly distributed across the four clusters, reflecting parallel-track R&D with no single approach yet dominant in the patent literature.
Geographic Origin of Protein Nanopore Innovation
Chinese academic institutions lead patent and literature activity in protein nanopore sequencing, with 6 records versus 4 from the US and 3 from Europe in this dataset.
Where Nanopore Protein Sequencing Creates Impact
Four application domains emerge from the retrieved patent and literature evidence, each with distinct technical requirements and commercial implications.
Proteomics & Precision Medicine
The primary driver for nanopore protein sequencing development is the need for single-cell-scale proteomics tools that function without chemical modification of samples or amplification steps. CONCEPT Lab (2020) frames protein sequencing directly in terms of "novel diagnostic and therapeutic approaches" enabled by single-molecule resolution. Istituto Italiano di Tecnologia (2022) explicitly targets single-cell proteomics and precision medicine as the end-use cases motivating solid-state nanopore development. Learn more about PatSnap's life sciences intelligence platform.
Clinical Diagnostics & Biomarker Detection
Chinese Academy of Sciences (2021) highlights applications to detection of protein biomarkers, peptides, and microorganisms, noting relevance to "new diagnoses and treatment methods." Southeast University (2020) categorizes clinical protein detection work including structural variant discrimination — directly applicable to disease biomarker profiling. NIH-funded biomarker research represents a key downstream application area.
Who is Filing Nanopore Protein Sequencing Patents?
Among retrieved results specifically addressing protein nanopore sequencing, innovation is concentrated in a small number of institutional players — primarily Chinese academic groups and select European research institutions — rather than distributed across large commercial entities. This suggests the field remains largely in the academic-to-early-patent transition phase.
China (CN/GB filings): The most active filers in this dataset for protein nanopore sequencing technology are Chinese academic institutions. Nanjing University holds the most advanced protein-sequencing-specific patent — the Nanopore channel monomolecular protein sequencer (GB jurisdiction, 2024, active). Southeast University (State Key Laboratory of Bioelectronics, Nanjing) has published multiple high-impact reviews on both solid-state and biological nanopore protein detection (2020, 2021). This concentration reflects substantial Chinese government investment in next-generation sequencing infrastructure. Track this cluster via PatSnap's IP analytics.
United States: University of Notre Dame pioneered sub-nanopore protein identification algorithms (2017). Drexel University established early protein-class sensing applications (2010). EPO-registered Illumina holds an active EP patent for a Nanopore sequencing method (2024) involving modified electrolytes in cis/trans well configurations — relevant to the broader platform on which protein sequencing methods may be deployed.
Europe: Italian institutions (CONCEPT Lab, Istituto Italiano di Tecnologia) are active in adaptive and optical nanopore approaches for protein sequencing. Aalto University (Finland) contributes DNA nanopore structural engineering concepts applicable to protein channels. PatSnap customers in European pharma and biotech actively monitor this cluster for freedom-to-operate analysis.
Four Directions Shaping Nanopore Protein Sequencing in 2026
The most recent filings and publications reveal decisive shifts from protein detection toward integrated protein sequencing device architectures.
Integrated Chip-Based Protein Sequencer Architectures
The Nanjing University GB patent (2024) represents the first chip-level device architecture in this dataset specifically designed for protein sequencing — integrating amino acid screening chips, sequence-reading chips, and data processing systems into a unified platform. This signals a shift from experimental proof-of-concept toward integrated device design. The PatSnap platform tracks this filing cluster in real time.
Chip-level integration · 2024 active patentLabel-Free Optical Readout in Solid-State Nanopores
Istituto Italiano di Tecnologia (2022) identifies optical sensing — using plasmonic or photonic enhancement in solid-state nanopores — as an emerging approach to overcome the amino acid discrimination limitations of ionic current alone. This multimodal signal acquisition direction could substantially increase sequence-read accuracy. IEEE publications track photonic nanopore developments closely.
Plasmonic enhancement · multimodal signalMonitor emerging nanopore protein sequencing filings as they publish
PatSnap Eureka alerts you to new patents across all four emerging directions in real time.
IP Strategy for Nanopore Protein Sequencing in 2026
Five strategic signals derived from the patent and literature evidence in this dataset, relevant to R&D teams, IP counsel, and competitive intelligence functions.
Significant IP White Space in Commercial Protein Sequencing
Commercial-entity patent filings specifically targeting protein sequencing (as distinct from DNA) are rare in this dataset — only Nanjing University (academic) and Illumina (DNA-platform adjacent) appear with relevant active patents. This represents a significant IP white space for companies developing purpose-built protein nanopore sequencing devices and chemistry. PatSnap Analytics can map the white space in detail.
File Around Each Technical Bottleneck Independently
As articulated in Istituto Italiano di Tecnologia (2022), the three bottlenecks — 20-amino acid discrimination, protein unfolding, and translocation speed control — remain the primary R&D targets. IP strategies should prioritize filing around solutions to each bottleneck independently, as combination patents will be harder to defend.
Monitor Chinese Institutional Patent Clusters for FTO Risk
With Nanjing University and multiple Chinese Academy of Sciences groups leading publication and patent activity specifically in protein nanopore sensing and sequencing, Western commercial players should monitor this cluster for licensing opportunities and freedom-to-operate risks as the technology approaches commercialization. Use PatSnap's open API for automated monitoring.
Algorithmic IP is as Critical as Device IP
The signal-processing challenge for 20-amino acid discrimination (versus 4 nucleotides) is substantially harder. The sub-nanopore "nanospectrum" algorithm approach (University of Notre Dame, 2017) and the integrated data processing systems in the Nanjing University chip patent suggest that machine learning–based basecalling equivalents for proteins will be foundational IP — comparable in strategic importance to ONT's DNA basecalling IP position.
Assess your freedom-to-operate in nanopore protein sequencing
AI-powered patent analysis across all four clusters and three bottleneck domains.
Nanopore Protein Sequencing — Key Questions Answered
Nanopore protein sequencing extends the ionic current-blockade sensing principles pioneered in DNA sequencing toward the far more complex challenge of identifying the 20 amino acid building blocks of proteins at the single-molecule level. The foundational mechanism threads a linearized analyte molecule through a nano-scale aperture embedded in a thin membrane while measuring characteristic ionic current blockade signatures.
As articulated in Label-Free Optical Analysis of Biomolecules in Solid-State Nanopores (Istituto Italiano di Tecnologia, 2022), the three bottlenecks are: 20-amino acid discrimination, protein unfolding, and translocation speed control. These remain the primary R&D targets in the field.
In this dataset, innovation in nanopore protein sequencing is concentrated in a small number of institutional players — primarily Chinese academic groups and select European research institutions. Nanjing University holds the most advanced protein-sequencing-specific patent in the dataset (Nanopore channel monomolecular protein sequencer, GB jurisdiction, 2024, active). Southeast University and the Chinese Academy of Sciences also contribute significant publication and patent activity.
The key technical distinctions from DNA sequencing include: (1) the absence of any protein amplification equivalent to PCR, making sensitivity an absolute requirement; (2) the 20-amino acid alphabet versus a 4-nucleotide alphabet, requiring finer discrimination resolution; and (3) the need to unfold native three-dimensional protein structures before translocation.
In this dataset, commercial-entity patent filings specifically targeting protein sequencing (as distinct from DNA) are rare — only Nanjing University (academic) and Illumina (DNA-platform adjacent) appear with relevant active patents. This represents a significant IP white space for companies developing purpose-built protein nanopore sequencing devices and chemistry.
The most recent filings and publications (2022–2024) reveal three emerging directions: (1) integrated chip-based protein sequencer architectures, exemplified by the Nanjing University GB patent (2024); (2) label-free optical readout in solid-state nanopores using plasmonic or photonic enhancement; and (3) electrolyte and pore chemistry engineering for enhanced ionic current resolution, covered in Illumina's EP patent (2024).
Still have questions? Let PatSnap Eureka answer them with live patent and literature data.
Ask PatSnap Eureka Your QuestionMap the Nanopore Protein Sequencing IP Landscape Before Your Competitors Do
Join 18,000+ innovators already using PatSnap Eureka to accelerate their R&D and de-risk their IP strategy.
References
- Nanopore channel monomolecular protein sequencer — Nanjing University, 2024, GB
- Nanopore sequencing method — Illumina, Inc., 2024, EP
- Label-Free Optical Analysis of Biomolecules in Solid-State Nanopores: Toward Single-Molecule Protein Sequencing — Istituto Italiano di Tecnologia, 2022
- Application of Solid-State Nanopore in Protein Detection — Southeast University (State Key Laboratory of Bioelectronics), 2020
- Adaptive nanopores: A bioinspired label-free approach for protein sequencing and identification — CONCEPT Lab, 2020
- Nanopore Technology for the Application of Protein Detection — Chinese Academy of Sciences, Chongqing School, 2021
- Single-molecule protein identification by sub-nanopore sensors — University of Notre Dame, 2017
- Nanopore-Based Devices for Bioanalytical Applications — Drexel University, 2010
- Recent advances in biological nanopores for nanopore sequencing, sensing and comparison of functional variations in MspA mutants — Southeast University, 2021
- Advanced DNA Nanopore Technologies — Aalto University, 2020
- Nanopore-Based Fourth-Generation DNA Sequencing Technology — Chinese Academy of Sciences, Chongqing Institute of Green and Intelligent Technology, 2015
- The evolution of nanopore sequencing — Shanghai Jiao Tong University, 2015
- Nanopore Technology and Its Applications in Gene Sequencing — Chinese Academy of Sciences, Shanghai Institute of Microsystem and Information Technology, 2021
- The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community — UC Santa Cruz Genomics Institute, 2016
- Nature — Nanopore sensing and single-molecule analysis literature
- NIH — Biomarker research and proteomics funding
- European Patent Office (EPO) — Nanopore sequencing patent registry
- World Health Organization (WHO) — Diagnostic technology standards
- IEEE — Photonic and plasmonic nanopore publications
All data and statistics on this page are sourced from the references above and from PatSnap's proprietary innovation intelligence platform. This landscape is derived from a limited set of patent and literature records retrieved across targeted searches and represents a snapshot of innovation signals within this dataset only.
PatSnap Eureka searches patents and research to answer instantly.